Effects of prolonged use of azithromycin in patients with cystic fibrosis: a meta-analysis.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Pulmonary Pharmacology & Therapeutics

• Publication date

  2008-10-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.pupt.2009.03.002PMID 19328860
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cystic Fibrosis

  2009influential reference
• Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators.

  2008cited by this paper
• Daily versus weekly azithromycin in cystic fibrosis patients

  2007cited by this paper
• Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes

  2007cited by this paper
• Quorum-Sensing Antagonistic Activities of Azithromycin in Pseudomonas aeruginosa PAO1: a Global Approach

  2006cited by this paper
• Azithromycin reduces spontaneous and induced inflammation in ΔF508 cystic fibrosis mice

  2006cited by this paper
• Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial

  2006influential reference
• Mucus clearance and lung function in cystic fibrosis with hypertonic saline.

  2006cited by this paper
• Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis.

  2005cited by this paper
• Azithromycin Exhibits Bactericidal Effects on Pseudomonas aeruginosa through Interaction with the Outer Membrane

  2005cited by this paper
• Effects of azithromycin on clinical isolates of Pseudomonas aeruginosa from cystic fibrosis patients.

  2005cited by this paper
• Heterogeneity of treatment response to azithromycin in patients with cystic fibrosis.

  2005cited by this paper
• Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis - art. no. CD002011.pub2

  2005cited by this paper
• Macrolide antibiotics for cystic fibrosis.

  2004cited by this paper
• Macrolides inhibit epithelial cell-mediated neutrophil survival by modulating granulocyte macrophage colony-stimulating factor release.

  2004cited by this paper
• Long term azithromycin therapy in cystic fibrosis patients: a study on drug levels and sputum properties.

  2004cited by this paper
• Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection.

  2004cited by this paper
• The effects of macrolides on inflammatory cells.

  2004cited by this paper
• Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial.

  2003influential reference
• Synergistic Activities of Macrolide Antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans Isolated from Patients with Cystic Fibrosis

  2002cited by this paper
• Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial.

  2002influential reference
• Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial

  2002influential reference
• Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature.

  2000cited by this paper
• Influence of macrolides on mucoid alginate biosynthetic enzyme from Pseudomonas aeruginosa.

  1997cited by this paper
• Management of pulmonary disease in patients with cystic fibrosis.

  1996influential reference
• Cystic fibrosis.

  1996cited by this paper
• Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin

  1996cited by this paper
• Human airway ion transport. Part one.

  1994cited by this paper
• Human airway ion transport. Part two.

  1994cited by this paper
• Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa

  1994cited by this paper
• Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.

  1994cited by this paper
• Profiles of outer membrane proteins and lipopolysaccharide of Pseudomonas aeruginosa grown in the presence of sub-MICs of macrolide antibiotics and their relation to enhanced serum sensitivity.

  1994cited by this paper
• Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics.

  1993cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper

• E. Coli Nissle 1917 Attenuates Antibiotic Mediated Neurotoxicity Possibly Through Gut-Brain Axis in Zebrafish.

  2026cites this paper
• Examining the safety and efficacy of Azithromycin in Cystic fibrosis: A systematic review and Meta-analysis.

  2025cites this paper
• Efficacy and safety of azithromycin in treating sinusitis patients: a systematic review and meta-analysis of randomized controlled trails

  2025cites this paper
• Macrolide antibiotics (including azithromycin) for cystic fibrosis.

  2024cites this paper
• Approaches to Targeting Bacterial Biofilms in Cystic Fibrosis Airways

  2021cites this paper
• Safety and efficacy of Azithromycin in prevention of chronic obstructive pulmonary disease exacerbation: systematic review and meta-analysis [version 1; peer review: 1 approved with reservations, 1 not approved]

  2021cites this paper
• Effectiveness and safety of medicines used in COPD patients

  2020cites this paper
• Macrolides for treatment of chronic obstructive pulmonary disease

  2019cites this paper
• Fitting Pieces into the Puzzle of Pseudomonas aeruginosa Type III Secretion System Gene Expression

  2019cites this paper
• Role of Probiotics in Mycoplasma pneumoniae Pneumonia in Children: A Short-Term Pilot Project

  2019cites this paper
• Safety and efficacy of Azithromycin in prevention of chronic obstructive pulmonary disease exacerbation: systematic review and meta-analysis

  2019cites this paper
• Xiyanping Plus Azithromycin Chemotherapy in Pediatric Patients with Mycoplasma pneumoniae Pneumonia: A Systematic Review and Meta-Analysis of Efficacy and Safety

  2019cites this paper
• Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomized controlled trials

  2018cites this paper
• Long-term macrolide treatment for the prevention of acute exacerbations in COPD: a systematic review and meta-analysis

  2018cites this paper
• Should Antibiotic Prophylaxis Be Routinely Used in Patients with Antibody-Mediated Primary Immunodeficiency?

  2018cites this paper
• A 12-week combination of clarithromycin and prednisone compared to a 24-week prednisone alone treatment in cryptogenic and radiation-induced organizing pneumonia

  2018cites this paper
• Effect of oral glycine on the clinical, spirometric and inflammatory status in subjects with cystic fibrosis: a pilot randomized trial

  2017cites this paper
• Diretrizes brasileiras de diagnóstico e tratamento da fibrose cística

  2017cites this paper
• Recurrent Acute Rhinosinusitis Prevention by Azithromycin in Children with Nonallergic Rhinitis.

  2017cites this paper
• Brazilian guidelines for the diagnosis and treatment of cystic fibrosis

  2017cites this paper
• Review Article Childhood Interstitial Lung Disease: Review on Diagnosis and Management

  2016cites this paper
• Childhood Interstitial Lung Disease: Review on Diagnosis and Management

  2016cites this paper
• Interstitial Lung Disease in Childhood: Clinical and Genetic Aspects

  2015cites this paper
• [National consensus regarding azithromycin use in cystic fibrosis].

  2015cites this paper
• Non-anti-infective effects of antimicrobials and their clinical applications: a review.

  2015cites this paper
• Prophylactic Use of Macrolide Antibiotics for the Prevention of Chronic Obstructive Pulmonary Disease Exacerbation: A Meta-Analysis

  2015cites this paper
• The Effects of Azithromycin on Dextran Sulfate Sodium Colitis in Mice

  2015cites this paper
• Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials.

  2014cites this paper
• Agents that increase AAM differentiation blunt RSV‐mediated lung pathology

  2014cites this paper
• Long-term, low-dose erythromycin monotherapy for Mycobacterium avium complex lung disease: a propensity score analysis.

  2014cites this paper
• The role of macrolides in asthma: current evidence and future directions.

  2014cites this paper
• Bronchiectasis: A Correct Diagnosis Needed for Proper Management

  2014cites this paper
• Bronchiectasis: A Correct Diagnosis Needed for Proper Management

  2014cites this paper
• Bronchiectasis: A Correct Diagnosis Needed for Proper Management

  2014cites this paper
• Macrolide Therapy Decreases Chronic Obstructive Pulmonary Disease Exacerbation: A Meta-Analysis

  2013cites this paper
• CHOLECYSTOKINETIC EFFECT OF AZITHROMYCIN ON HEALTHY SUBJECTS: A PLACEBO- CONTROLLED CROSSOVER STUDY

  2013cites this paper
• Effects of azithromycin in Pseudomonas aeruginosa burn wound infection.

  2013cites this paper
• Antibiotic prophylaxis in primary immune deficiency disorders.

  2013cites this paper
• Infections à Pseudomonas aeruginosa

  2013cites this paper
• Biofilm Matrix and Its Regulation in Pseudomonas aeruginosa

  2013cites this paper
• Azithromycin in cystic fibrosis : pharmacokinetic and therapeutic aspects of maintenance therapy

  2012cites this paper
• Long‐term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments

  2012cites this paper
• Macrolides in Chronic Inflammatory Skin Disorders

  2012cites this paper
• Asian Economic and Social Society Gastrokinetic effect of azithromycin : An in vivo sonographic study on healthy volunteers

  2012cites this paper
• Glucocorticoids reduce inflammation in cystic fibrosis bronchial epithelial cells.

  2012cites this paper
• Gastrokinetic Effect of Azithromycin: An in Vivo Sonographic Study on Healthy Volunteers

  2012cites this paper
• Pathogen- and Host-Directed Anti-Inflammatory Activities of Macrolide Antibiotics

  2012cites this paper
• Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells.

  2012influential citation
• Long‐term effect of chronic intravenous and inhaled nephrotoxic antibiotic treatment on the renal function of patients with cystic fibrosis

  2012cites this paper
• Azithromycin maintenance therapy in patients with cystic fibrosis: A dose advice based on a review of pharmacokinetics, efficacy, and side effects

  2012cites this paper
• Macrolide antibiotics for cystic fibrosis.

  2012cites this paper
• Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset

  2011cites this paper
• Macrolides, Azalides, and Ketolides

  2011cites this paper
• Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review.

  2011cites this paper
• The acute interstitial nephritis induced by azithromycin

  2011cites this paper
• Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases

  2011cites this paper
• The Role of Macrolides in Noncystic Fibrosis Bronchiectasis

  2011cites this paper
• Azithromycin Inhibits Expression of the GacA-Dependent Small RNAs RsmY and RsmZ in Pseudomonas aeruginosa

  2011cites this paper
• Advances in Pharmacological Treatment of Cystic Fibrosis

  2010cites this paper
• The role of azithromycin in patients with cystic fibrosis.

  2010cites this paper
• Azithromycin paradox in the treatment of cystic fibrosis airway disease.

  2010cites this paper
• Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer?

  2010cites this paper
• Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.

  2010cites this paper
• Étude du mode d'action antimicrobien de la pré-élafine contre Pseudomonas aeruginosa

  2010cites this paper
• Comparison of the Effect of Azithromycin Versus Erythromycin on Antroduodenal Pressure Profiles of Patients with Chronic Functional Gastrointestinal Pain and Gastroparesis

  2010cites this paper
• Potential of anti-inflammatory treatment for cystic fibrosis lung disease

  2010cites this paper
• Interstitial lung diseases in children

  2010cites this paper
• Azithromycin suppresses interleukin-12p40 expression in lipopolysaccharide and interferon-γ stimulated macrophages

  2009cites this paper